Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition

Biochemical and Biophysical Research Communications
Toshifumi FujiwaraKen-Ichi Kozaki

Abstract

Genetic amplification, overexpression, and increased signaling from the epidermal growth factor receptor (EGFR) are often found in oral squamous cell carcinoma (OSCC) and thus EGFR is frequently targeted molecularly by the therapeutic antibody cetuximab. We assessed effects of cetuximab in control of EGF-driven malignant traits of OSCC cells. EGF stimulation promoted progression level of mesenchymal traits in OSCC cells, which were attenuated by cetuximab but incompletely. We pursued a potential mechanism underlying such incomplete attenuation of OSCC malignant traits. Cetuximab promoted secretion of EGFR-EVs by OSCC cells and failed to inhibit EGF-driven secretion of EGFR-EVs. Cetuximab was also found to be robustly secreted with the EGFR-EVs by the OSCC cells. Thus, EGF promotes the level of mesenchymal traits of OSCC cells and secretion of EGFR-EVs, which involve cetuximab resistance.

Citations

Feb 15, 2020·International Journal of Molecular Sciences·Tami YapAntonio Celentano
Nov 16, 2018·International Journal of Oncology·Rieko ShimizuAkira Sasaki
Sep 20, 2019·International Journal of Molecular Sciences·Eman A TahaTakanori Eguchi
Oct 23, 2020·International Journal of Cancer. Journal International Du Cancer·Zihang LingXiaoan Tao
Nov 22, 2020·Journal of Clinical Medicine·Takanori Eguchi
Jan 1, 2021·Cancers·Allison A FitzgeraldLouis M Weiner
Nov 19, 2020·Cell Death & Disease·Xingli DongYong Li
Mar 16, 2021·Frontiers in Oncology·Sandra Ortiz-CuaranPierre Saintigny
May 28, 2021·International Journal of Nanomedicine·Sangiliyandi GurunathanJin-Hoi Kim
Oct 24, 2020·European Journal of Pharmacology·Seyed Ali MosaddadHamid Tebyanian
Jan 16, 2022·Seminars in Cancer Biology·Takanori EguchiStuart K Calderwood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.